Igor Bilinsky, Sr VP, Corporate Development at Fresh Tracks Therapeutics, holds 193.80K shares in Fresh Tracks Therapeutics (Ticker: FRTX), holds ― shares in Tecogen (Ticker: TGEN), holds ― shares in Oncternal Therapeutics (Ticker: ONCT).
What is the percentage of profitable transactions made by Igor Bilinsky?
The percentage of profitable transactions made by Igor Bilinsky is ―.
What is the average return per transaction made by Igor Bilinsky?
The average return per transaction made by Igor Bilinsky is ―.
What stocks does Igor Bilinsky hold?
Igor Bilinsky holds: FRTX, TGEN, ONCT, IOVA, ~RXDX stocks.
What was Igor Bilinsky’s latest transaction?
Igor Bilinsky latest transaction was an Uninformative Sell of $868.02.
What was Igor Bilinsky's most profitable transaction?
Igor Bilinsky’s most profitable transaction was an Informative Buy of FRTX stock on January 14, 2014. The return on the trade was -26.40%.
What is Igor Bilinsky's role in Fresh Tracks Therapeutics?
Igor Bilinsky's role in Fresh Tracks Therapeutics is Sr VP, Corporate Development.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.